Aterian (NASDAQ:ATER – Get Free Report) declared that its Board of Directors has authorized a stock repurchase plan on Tuesday, March 18th, RTT News reports. The company plans to repurchase $3.00 million in shares. This repurchase authorization permits the company to buy up to 16.2% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its stock is undervalued.
Aterian Price Performance
ATER opened at $2.35 on Friday. The stock has a market capitalization of $20.57 million, a price-to-earnings ratio of -0.86 and a beta of 2.03. The business has a 50-day moving average of $2.19 and a two-hundred day moving average of $2.56. Aterian has a 12 month low of $1.86 and a 12 month high of $3.95.
Aterian (NASDAQ:ATER – Get Free Report) last posted its quarterly earnings results on Tuesday, March 18th. The company reported ($0.18) EPS for the quarter, beating the consensus estimate of ($0.58) by $0.40. The company had revenue of $24.61 million during the quarter, compared to analysts’ expectations of $23.48 million. Aterian had a negative return on equity of 56.01% and a negative net margin of 17.05%.
Aterian Company Profile
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.
Featured Articles
- Five stocks we like better than Aterian
- Investing in Travel Stocks Benefits
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- 5 discounted opportunities for dividend growth investors
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- How is Compound Interest Calculated?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.